Table 2.
In-person regression results by disease cohort; for each disease cohort the dependent variable is the natural logarithm of the number of in-person visits during the 12-month pandemic period, June 2020 to May 2021 (P values are reported within parentheses).
|
|
Anxiety, r (P value) | Depression, r (P value) | Diabetes, r (P value) | Kidney failure, r (P value) | Heart failure, r (P value) | Cancer, r (P value) | |
| Intercept | 1.12 (<.001) | 1.14 (<.001) | 1.37 (<.001) | 1.78 (<.001) | 1.84 (<.001) | 1.38 (<.001) | |
| Pre–COVID-19 visits | 0.08 (<.001) | 0.08 (<.001) | 0.08 (<.001) | 0.06 (<.001) | 0.07 (<.001) | 0.07 (<.001) | |
| Charlson Index | –0.01 (<.001) | –0.02 (<.001) | –0.02 (<.001) | –0.03 (<.001) | –0.03 (<.001) | –0.03 (<.001) | |
| Age (years) | 0.005 (<.001) | 0.004 (<.001) | 0.0004 (.14) | –0.004 (<.001) | –0.01 (<.001) | 0.001 (.002) | |
| Sex | |||||||
|
|
Male | –0.16 (<.001) | –0.14 (<.001) | –0.10 (<.001) | –0.08 (<.001) | –0.06 (<.001) | –0.10 (<.001) |
|
|
Unknown | 0.27 (.47) | 0.05 (.89) | –0.34 (.52) | —a | — | — |
| Race | |||||||
|
|
Other | –0.15 (<.001) | –0.17 (<.001) | –0.16 (<.001) | –0.16 (<.001) | –0.17 (<.001) | –0.22 (<.001) |
|
|
White | –0.07 (<.001) | –0.07 (<.001) | –0.03 (<.001) | –0.05 (<.001) | –0.02 (.30) | –0.1 (<.001) |
| SVIb | |||||||
|
|
High | –0.002 (.82) | 0.02 (.09) | 0.03 (.004) | 0.02 (.16) | 0.01 (.49) | 0.07 (<.001) |
|
|
Medium | 0.05 (<.001) | 0.07 (<.001) | 0.1 (<.001) | 0.09 (<.001) | 0.1 (<.001) | 0.13 (<.001) |
|
|
Missing | –0.01 (.88) | –0.05 (.31) | –0.09 (.03) | –0.05 (.52) | –0.01 (.95) | –0.02 (.77) |
aNot applicable.
bSVI: Social Vulnerability Index.